MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

June 2005


Letter to the Editor

The FDA, Vioxx®, and the Repercussions of Direct-to-Consumer Advertising

John A. Frantz, MD

Health Care and Law

Psychologists Gain a Foothold in the Battle for Prescribing Privileges

Dr. Field discusses the trend of states allowing psychologists to prescribe psychotropic medications.
Robert I. Field, JD, MPH, PhD

Book Review

The Language of Life: How Cells Communicate in Health and Disease

Author: Debra Niehoff, PhD
Reviewed by Mark Noble, PhD

Evaluation of Three 5-HT3 Receptor Antagonists in the Prevention of Postoperative Nausea and Vomiting in Adults

The authors compare the efficacy of three antiemetic medications for PONV: ondansetron (Zofran®), granisetron (Kytril®), and dolasetron (Anzemet®).
Shan Wang, PharmD, Joseph Greco, MD, Reena A. Joseph, PharmD Candidate, Martin Feuerman, MS, and Brian Malone, MS

Consensus Panel Recommendations for the Assessment and Management of Breakthrough Pain. Part 2 Management

The authors continue their discussion of pharmacological and nonpharmacological therapies with a focus on criteria for the best agent, the subtypes of breakthrough pain, and the economic and quality-of life considerations.
Daniel Bennett, MD, Allen W. Burton, MD, Scott Fishman, MD, Barry Fortner, PhD, Bill McCarberg, MD, Chris Miaskowski, PhD, RN, David Nash, MD, MBA, Marco Pappagallo, MD, Richard Payne, MD, James Ray, PharmD, Eugene R. Viscusi, MD, and Winston Wong, PharmD



Happy Anniversary!

David Nash, MD, MBA, describes the mission and vision of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR) upon the occasion of its 10th anniversary.
David Nash, MD, MBA

Medication Errors

It Doesn’t Pay to Play the Percentages with Drug Dosages

Matthew Grissinger, RPh, FASCP, discusses some common and dangerous problems associated with the dosing of epinephrine and other drugs used for resuscitating patients.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Pharmacists Try to Reverse CMS Refusal to Fund Second-Year Training for Residents

Stephen Barlas comments on the refusal of the Centers for Medicare & Medicaid Services to fund pharmacy residents in their second year of training.
Stephen Barlas

Drug Forecast

Ezetimibe/Simvastatin (Vytorin®): A Dual Approach to Treating Hyperlipidemia

The authors review the benefits of ezetimibe/simvastatin (Vytorin®) as a therapeutic approach for hyperlipidemia.
Katrina Touchstone, PharmD Candidate, Laura Stark, PharmD Candidate, Marlon Honeywell, PharmD, Marvin Scott, PharmD, and Evans Branch III, PharmD

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.